US Capital Chosen As Advisor On A Large Capital Raise By A Company Behind Silver-Cannabinoid Formula Against Drug-Resistant Infections
US Capital has been engaged by Andira Pharmaceuticals as its strategic advisor on a multi-million dollar capital raise round.
